Abstract
The antifungal susceptibility of 35 Candida lusitaniae isolates was determined in vitro by the National Committee for Clinical Laboratory Standards (NCCLS) M27-P macrodilution methodology. All the isolates were susceptible to ketoconazole, itraconazole and fluconazole. Of the 35 isolates, eight (23%) were resistant to flucytosine. For amphotericin B, M27-P yielded a narrow range of MICs (0.06-0.5 mg/L). We therefore investigated the activity of this drug by reading MICs at 72 h and by using alternative media, namely casitone complex medium (CCM) and antibiotic medium 3 (M-3). Reading at 72 h did not generate reproducible results. CCM and M-3 provided better discrimination between the isolates but did not change the rank order of the MICs. We thus concluded that all the isolates were susceptible to amphotericin B. We also conducted an evaluation with the Etest method according to the manufacturer's instructions with RPMI 1640 agar, CCM and the alternative semi-synthetic medium (SSM). For RPMI 1640, agreements +/-2 dilutions were 58% for amphotericin B, 92% for flucytosine, 57% for ketoconazole, 92% for fluconazole and 74% for itraconazole. CCM did not improve the agreement rates between the two methods but it led to better growt...Continue Reading
Citations
Oct 12, 2000·Diagnostic Microbiology and Infectious Disease·B PosteraroG Fadda
Sep 12, 2003·Diagnostic Microbiology and Infectious Disease·Anne FavelPatrick Regli
Jan 13, 1999·Diagnostic Microbiology and Infectious Disease·M A PfallerA Bolmström
Jan 10, 2002·Infectious Disease Clinics of North America·M A Pfaller, W L Yu
Jan 18, 2002·Antimicrobial Agents and Chemotherapy·Erika J ErnstMichael E Klepser
Oct 5, 2001·Clinical Microbiology Reviews·J H RexD W Warnock
Jan 4, 2001·Journal of Clinical Microbiology·F PeyronA Bolmström
Oct 30, 2001·Journal of Clinical Microbiology·F FrançoisJ Villard
Mar 8, 2003·Journal of Clinical Microbiology·M J MaxwellM A Pfaller
Dec 17, 2008·Diagnostic Microbiology and Infectious Disease·David ReboutierNicolas Papon
Dec 9, 2008·Yeast·Stéphanie BoisnardNicolas Papon
Apr 8, 1998·Journal of Chemotherapy·I M GouldA Kunova
May 17, 2002·The Journal of Hospital Infection·V Krcmery, A J Barnes
Feb 25, 1999·FEMS Immunology and Medical Microbiology·V KrcmeryJ Hanzen
Sep 28, 2018·Expert Review of Anti-infective Therapy·Sean KeaneIgnacio Martin-Loeches
Sep 11, 2003·Medical Mycology·B Fernández-TorresJ Guarro
Jan 17, 2002·The Annals of Pharmacotherapy·P Pietrucha-DilanchianA E Lechin